As already mentioned, PGC1α protects against NASH progression and is encoding by PPARGC1A gene, and its promoter methylation is increased in adult patients with NASH compared to those isolated steatosis, correlating with insulin resistance, reduced mitochondrial DNA, and decreased gene transcriptional activity [263]. This evidence concerns the gene PPARGC1A and metabolic dysfunction-associated steatohepatitis.